Broadcom vs. Micron Technology: Which Technology Stock Is a Better Buy in 2026?

Broadcom is presented as the preferred long-term AI semiconductor investment, supported by FY2025 revenue of $63.9 billion (+23.9%), a 36.2% net margin, $26.9 billion in free cash flow, and management supply commitments targeting another doubling of AI revenue in each of the next two years. Micron delivered faster FY2025 revenue growth of 48.9% to $37.4 billion and $8.5 billion of net income, while trading at a lower 6.8x forward P/E versus Broadcom's 20.9x. The analysis favors Broadcom's custom AI-chip relationships and more durable revenue visibility, while highlighting customer concentration, cyclicality, regulatory, geopolitical, and supply-chain risks for both companies.

Analysis

The relevant distinction is not AI exposure but earnings convexity. AVGO monetizes AI through differentiated connectivity and custom silicon with software cash flows cushioning a hyperscaler digestion cycle; MU monetizes the same buildout through HBM/DRAM pricing, where incremental supply can rapidly erase margins. A pause in AI capex would therefore likely compress MU earnings estimates materially faster, while AVGO's multiple is more exposed to a de-rating if custom-ASIC growth fails to meet already elevated expectations.

The non-obvious beneficiary of continued custom-ASIC adoption is TSM: each incremental AVGO accelerator program raises leading-edge wafer and advanced-packaging demand, while it can displace some NVDA merchant-GPU content at the system level. Conversely, HBM demand is not a pure MU story; SK Hynix remains the key competitive benchmark, and any qualification gains by Samsung or capacity ramp ahead of demand would pressure MU's pricing power even if AI unit demand stays robust.

Near term, this article is not a standalone catalyst and should not drive position sizing. Over the next 1-3 months, monitor hyperscaler capex commentary, AVGO AI-revenue backlog conversion, TSM CoWoS utilization, and HBM contract-price trends. The 6-18 month question is whether custom ASICs expand the total AI market or merely shift spend from NVDA; the latter supports AVGO but weakens the broader semiconductor valuation complex.

Consensus likely overstates AVGO's revenue visibility by treating customer commitments as immutable demand. A single major customer pushing out a program can create an outsized estimate reset because custom silicon has long design cycles and concentrated economics. MU looks optically inexpensive on peak-cycle earnings; the appropriate entry signal is sustained HBM pricing discipline and evidence that industry capex is not accelerating into 2027 supply.

Key Decisions for Investors

• Maintain a quality-biased AI exposure via long AVGO versus short MU in equal dollar terms over a 3-6 month horizon; the pair expresses preference for higher durability of gross margin and cash conversion rather than outright semiconductor beta. Reassess if MU HBM pricing and gross-margin guidance continue to rise while AVGO reports any material custom-ASIC program delay.
• For incremental AVGO exposure, wait for post-earnings confirmation that AI revenue/backlog conversion remains intact rather than chasing a pre-event multiple expansion. A 10-15% downside from a guidance miss is plausible given concentration and expectations; upside requires estimates moving higher, not merely in-line results.
• Use TSM as the cleaner second-order long on sustained custom-ASIC and HBM demand, with a 6-18 month horizon. Falsify on disclosed advanced-packaging capacity underutilization, material export-control escalation, or a broad cut in hyperscaler capex plans.
• Do not initiate a standalone MU long solely on its lower forward multiple. Set an alert for evidence of new DRAM/NAND capacity additions or declining HBM contract pricing; either would indicate that the market is beginning to discount a memory-cycle peak and would favor reducing semiconductor cyclicals.